Surgical Navigation for Lateral Pelvic Lymph Node Dissection in Rectal Cancer
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Lateral pelvic lymph node dissection (LPLND) provides oncologic benefits in patients with rectal cancer who have enlarged lateral nodes. However, anatomical complexity in the lateral pelvis makes the procedure technically challenging, which may lead to increased intraoperative blood loss, prolonged operative time, postoperative complications and incomplete lymph node dissection. To address such technical challenges, various surgical navigation tools have been developed. In this up-to-date narrative review, we summarize the current evidence on surgical navigation for LPLND and discuss their advantages, limitations and future perspectives.
References
1.
Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T
. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2019; 25(1):1-42.
PMC: 6946738.
DOI: 10.1007/s10147-019-01485-z.
View
2.
Georgiou P, Tan E, Gouvas N, Antoniou A, Brown G, Nicholls R
. Extended lymphadenectomy versus conventional surgery for rectal cancer: a meta-analysis. Lancet Oncol. 2009; 10(11):1053-62.
DOI: 10.1016/S1470-2045(09)70224-4.
View
3.
Benson A, Venook A, Al-Hawary M, Azad N, Chen Y, Ciombor K
. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2022; 20(10):1139-1167.
DOI: 10.6004/jnccn.2022.0051.
View
4.
Ogura A, Konishi T, Beets G, Cunningham C, Garcia-Aguilar J, Iversen H
. Lateral Nodal Features on Restaging Magnetic Resonance Imaging Associated With Lateral Local Recurrence in Low Rectal Cancer After Neoadjuvant Chemoradiotherapy or Radiotherapy. JAMA Surg. 2019; 154(9):e192172.
PMC: 6613303.
DOI: 10.1001/jamasurg.2019.2172.
View
5.
Ogura A, Konishi T, Cunningham C, Garcia-Aguilar J, Iversen H, Toda S
. Neoadjuvant (Chemo)radiotherapy With Total Mesorectal Excision Only Is Not Sufficient to Prevent Lateral Local Recurrence in Enlarged Nodes: Results of the Multicenter Lateral Node Study of Patients With Low cT3/4 Rectal Cancer. J Clin Oncol. 2018; 37(1):33-43.
PMC: 6366816.
DOI: 10.1200/JCO.18.00032.
View